Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means" video ...

You may like Anthropic just launched Claude 3.7 Sonnet with new 'hybrid reasoning model' — and it could be a game changer I tested Grok vs. Claude with 5 prompts to crown a winner Unfortunately ...

Sonnet has treated 7 patients over 2 months on average and expects to enroll up to 18 patients with unresectable, metastatic LMS or LPS in this open-label, single-arm expansion cohort. Patients ...